Llwytho...

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD

Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients. In this regard, global COPD treatment guidelines have recognized the importance of inhaler d...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pulm Ther
Prif Awduron: D’Urzo, Anthony, Chapman, Kenneth R., Donohue, James F., Kardos, Peter, Maleki-Yazdi, M. Reza, Price, David
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Healthcare 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6967354/
https://ncbi.nlm.nih.gov/pubmed/32026426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-019-0090-1
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!